Upstream commences testing of the FAST-TRAC cohort

The journey towards fully developing a diagnostic for people who fit the troponin grey zone is now one step closer, with testing starting on the FAST-TRAC cohort.

This cohort includes 1,500 chest pain patients from the US and Switzerland who presented to the emergency department. The aim of this testing phase is to validate Upstream’s diagnostic technology in rapidly and accurately triaging chest-pain patients who fall into a grey-zone with existing troponin assays.